365 related articles for article (PubMed ID: 26467074)
1. Prevalence and correlates of QTc prolongation in Italian psychiatric care: cross-sectional multicentre study.
Nosè M; Bighelli I; Castellazzi M; Martinotti G; Carrà G; Lucii C; Ostuzzi G; Sozzi F; Barbui C;
Epidemiol Psychiatr Sci; 2016 Dec; 25(6):532-540. PubMed ID: 26467074
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic Dose Mediates the Association between Polypharmacy and Corrected QT Interval.
Barbui C; Bighelli I; Carrà G; Castellazzi M; Lucii C; Martinotti G; Nosè M; Ostuzzi G;
PLoS One; 2016; 11(2):e0148212. PubMed ID: 26840602
[TBL] [Abstract][Full Text] [Related]
3. Proarrhythmic risk with antipsychotic and antidepressant drugs: implications in the elderly.
Vieweg WV; Wood MA; Fernandez A; Beatty-Brooks M; Hasnain M; Pandurangi AK
Drugs Aging; 2009; 26(12):997-1012. PubMed ID: 19929028
[TBL] [Abstract][Full Text] [Related]
4. Electrocardiogram Alterations Associated With Psychotropic Drug Use and CACNA1C Gene Variants in Three Independent Samples.
Fabbri C; Boriani G; Diemberger I; Filippi MG; Ravegnini G; Hrelia P; Minarini A; Albani D; Forloni G; Angelini S; Serretti A
Basic Clin Pharmacol Toxicol; 2017 May; 120(5):482-490. PubMed ID: 27893184
[TBL] [Abstract][Full Text] [Related]
5. Electrocardiogram Characteristics and Their Association With Psychotropic Drugs Among Patients With Schizophrenia.
Polcwiartek C; Kragholm K; Hansen SM; Atwater BD; Friedman DJ; Barcella CA; Graff C; Nielsen JB; Pietersen A; Nielsen J; Søgaard P; Torp-Pedersen C; Jensen SE
Schizophr Bull; 2020 Feb; 46(2):354-362. PubMed ID: 31219596
[TBL] [Abstract][Full Text] [Related]
6. QTc prolongation, torsades de pointes, and psychotropic medications.
Beach SR; Celano CM; Noseworthy PA; Januzzi JL; Huffman JC
Psychosomatics; 2013; 54(1):1-13. PubMed ID: 23295003
[TBL] [Abstract][Full Text] [Related]
7. QTc Prolongation Associated With Psychiatric Medications: A Retrospective Cross-Sectional Study of Adult Inpatients.
Shao W; Ayub S; Drutel R; Heise WC; Gerkin R
J Clin Psychopharmacol; 2019; 39(1):72-77. PubMed ID: 30531476
[TBL] [Abstract][Full Text] [Related]
8. Leading 20 drug-drug interactions, polypharmacy, and analysis of the nature of risk factors due to QT interval prolonging drug use and potentially inappropriate psychotropic use in elderly psychiatry outpatients.
Das B; Ramasubbu SK; Agnihotri A; Kumar B; Rawat VS
Ther Adv Cardiovasc Dis; 2021; 15():17539447211058892. PubMed ID: 34841978
[TBL] [Abstract][Full Text] [Related]
9. [Minimizing the risks associated with QTc prolongation in people with schizophrenia. A consensus statement by the Cardiac Safety in Schizophrenia Group].
Ames D; Camm J; Cook P; Falkai P; Gury C; Hurley R; Johnson G; Piepho R; Vieweg V;
Encephale; 2002; 28(6 Pt 1):552-62. PubMed ID: 12506268
[TBL] [Abstract][Full Text] [Related]
10. [Psychotropic drugs and QTc prolongation].
De Wit LE; van Stiphout F; Groeneveld SA; Hassink RJ; Dekker D
Ned Tijdschr Geneeskd; 2021 Jul; 165():. PubMed ID: 34346615
[TBL] [Abstract][Full Text] [Related]
11. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
Mayet S; Gossop M; Lintzeris N; Markides V; Strang J
Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918
[TBL] [Abstract][Full Text] [Related]
12. QTc interval in patients with schizophrenia receiving antipsychotic treatment as monotherapy or polypharmacy.
Elliott A; Mørk TJ; Højlund M; Christensen T; Jeppesen R; Madsen N; Viuff AG; Hjorth P; Nielsen JC; Munk-Jørgensen P
CNS Spectr; 2018 Aug; 23(4):278-283. PubMed ID: 28659221
[TBL] [Abstract][Full Text] [Related]
13. Frequency, characteristics and nature of risk factors associated with use of QT interval prolonging medications and related drug-drug interactions in a cohort of psychiatry patients.
Das B; Rawat VS; Ramasubbu SK; Kumar B
Therapie; 2019 Dec; 74(6):599-609. PubMed ID: 31053339
[TBL] [Abstract][Full Text] [Related]
14. First-generation antipsychotics and QTc: any role for mediating variables?
Carrà G; Crocamo C; Bartoli F; Lax A; Tremolada M; Lucii C; Martinotti G; Nosè M; Bighelli I; Ostuzzi G; Castellazzi M; Clerici M; Barbui C;
Hum Psychopharmacol; 2016 Jul; 31(4):313-8. PubMed ID: 27245736
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and predictors of QTc prolongation in patients seen in a clozapine clinic in a real-world setting in Australia.
Sankaranarayanan A; Kazi S; Andrade C
Schizophr Res; 2024 Jun; 268():145-149. PubMed ID: 37770378
[TBL] [Abstract][Full Text] [Related]
16. Risk management of QTc-prolongation in patients receiving haloperidol: an epidemiological study in a University hospital in Belgium.
Vandael E; Vandenberk B; Vandenberghe J; Spriet I; Willems R; Foulon V
Int J Clin Pharm; 2016 Apr; 38(2):310-20. PubMed ID: 26749342
[TBL] [Abstract][Full Text] [Related]
17. Antipsychotic drugs and QT interval prolongation.
Zareba W; Lin DA
Psychiatr Q; 2003; 74(3):291-306. PubMed ID: 12918603
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for QT prolongation associated with acute psychotropic drug overdose.
Miura N; Saito T; Taira T; Umebachi R; Inokuchi S
Am J Emerg Med; 2015 Feb; 33(2):142-9. PubMed ID: 25445869
[TBL] [Abstract][Full Text] [Related]
19. QTc interval measurement and metabolic parameters in psychiatric patients taking typical or atypical antipsychotic drugs: a preliminary study.
Mackin P; Young AH
J Clin Psychiatry; 2005 Nov; 66(11):1386-91. PubMed ID: 16420075
[TBL] [Abstract][Full Text] [Related]
20. Psychotropic drugs associated with corrected QT interval prolongation.
van Noord C; Straus SM; Sturkenboom MC; Hofman A; Aarnoudse AJ; Bagnardi V; Kors JA; Newton-Cheh C; Witteman JC; Stricker BH
J Clin Psychopharmacol; 2009 Feb; 29(1):9-15. PubMed ID: 19142100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
